AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| JHL | Notice of Annual General Meeting/Proxy Form | 23/04/18 | ||
| JHL | Change of Director's Interest Notice | 13/04/18 | ||
| JHL | Apppendix 4G & 2017 Corporate Governance Statement | 27/02/18 | ||
| JHL | Appendix 4E and 2017 Annual Report | PRICE SENSITIVE | 27/02/18 | |
| JHL Notice of Annual General Meeting/Proxy Form | |||
| 23/04/18 | |||
| JHL Change of Director's Interest Notice | |||
| 13/04/18 | |||
| JHL Apppendix 4G & 2017 Corporate Governance Statement | |||
| 27/02/18 | |||
| JHL Appendix 4E and 2017 Annual Report | |||
| 27/02/18 | PRICE SENSITIVE | ||
